Zeria Pharmaceutical Co 4559.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4559.T. It has been listed since 22 December 1998. In the fiscal year to 31 March 2026, it reported revenue of ¥89.16bn and net income of ¥8.45bn. At that date it held total assets of ¥179.70bn and shareholders' equity of ¥108.40bn.

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Sachiaki IbeChairman of the Board, Chief Executive Officer, Representative Director, since 1972
• Mr. Mitsuhiro IbePresident, Chief Operating Officer, Representative Director, since 2010
• Mr. Yasuhisa TanakaExecutive Officer, Chief Director of Finance and Accounting, Director of Finance, Director of Accounting
• Mr. Yuuki OkazawaManaging Executive Officer, Chief Director of Administration, Director of Human Resources, Director, since 2020
• Mr. Hiroki KatoManaging Executive Officer, Chief Director of Asia Business, Director of Asia Business Planning, Director of Asia Business Development, since 2011
• Mr. Kazuhiro AkibaExecutive Officer, Director of Pharmaceutical Sales
• Mr. Kenji KusanoExecutive Officer, Chief Director of Consumer Health Care Sales, since 2017
• Mr. Yoshihiro HiragaExecutive Officer, Chief Director of Research & Development, since 2009
• Mr. Mitsuru IwaiExecutive Officer, Chief Director of Production & Logistics
• Mr. Toshiaki KawagoeExecutive Officer, Chief Director of Reliability Assurance, since 2015
• Mr. Masakazu SakuraiExecutive Officer, Chief Director of European Business, Director of European Business
• Mr. Kenichi SuzukiExecutive Officer, Senior Director of Corporate Planning, Director of Corporate Strategy Promotion

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.